People with Parkinson's disease who have a pacemaker-like device implanted in the brain spend an extra four-plus hours a day free of tremors and involuntary movements than they do on medication, ...

A team of experts from the Icahn School of Medicine at Mount Sinai has become the first in the United States to perform a ...

Now, however, stem cells are changing the equation – allowing scientists to effectively re-create the human brain inside a ...

Parkinson’s disease is set to rise dramatically, with cases expected to more than double by 2050, largely due to an aging ...

Celon Pharma’s PDE10A inhibitor has reduced involuntary movements in a phase 2 trial of individuals with Parkinson’s disease.

Researchers have revealed neural circuits in the brainstem that are crucially involved in implementing decisions by ...